Clinical Research Directory
Browse clinical research sites, groups, and studies.
68Ga-PFD3 PET Imaging for the Diagnosis and Evaluation of Small Cell Lung Cancer
Sponsor: Peking University First Hospital
Summary
This study aims to investigate and evaluate the safety and performance of a novel probe, PFD3, for the diagnosis and assessment of patients with small cell lung cancer (SCLC).
Official title: Targeting Delta-like Ligand 3 (DLL3) With 68Ga-PFD3 PET/CT for the Diagnosis and Assessment of Small Cell Lung Cancer (SCLC)
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
30
Start Date
2025-06-01
Completion Date
2027-12-31
Last Updated
2026-04-02
Healthy Volunteers
No
Conditions
Interventions
Sequential [18F]-FDG PET/CT
Based on individual clinical circumstances, eligible patients will undergo sequential \[18F\]FDG PET/CT and \[68Ga\]Ga-PFD3 PET/CT scans within one week.
[68Ga]Ga-PFD3 PET/CT scan
Based on individual clinical circumstances, eligible patients will undergo sequential \[18F\]FDG PET/CT and \[68Ga\]Ga-PFD3 PET/CT scans within one week.
Locations (1)
Peking university first hospital nuclear medicine
Beijing, Beijing Municipality, China